CT26-hHER2 modelintracerebroventricular GL261 gliomasID8 tumorsICIs
…ignificantly reduced tumor burden and improved survival. In the CT26-hHER2 model, combining ICIs with antibody-drug conjugates (ADCs) enhanced a…
Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
This institution is selected. Its supporting articles are shown below.
…ignificantly reduced tumor burden and improved survival. In the CT26-hHER2 model, combining ICIs with antibody-drug conjugates (ADCs) enhanced a…